LVAD as a Treatment Option

The FDA approved the HeartMate® LVAD for destination therapy based on results of the landmark REMATCH clinical trial that demonstrated the device nearly doubled and tripled survival at one and two years respectively, and improved quality of life in this patient group. Physicians at Baylor St. Luke’s Medical Center’s Cooley Transplant Center and the Texas Heart® Institute have implanted over 1,000 LVAD devices since 1986.

The Texas Heart® Institute at Baylor St. Luke’s Medical Center originated the laboratory and clinical research on all LVAD pumps including the HeartMate® XVE, HeartMate® II, Jarvik, and HeartWare®, and implanted the first 20 HeartMate® LVADs in the world. O.H. “Bud” Frazier, MD, and his team initiated the research which led to the REMATCH study and have implanted more of the devices than any other heart center worldwide.

If you suffer from congestive heart failure and want to know if you may be a candidate for an LVAD as a permanent implant, please contact us at 832-355-2285 or toll free at 877-685-0361.